Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human ACVR1 Stable Cell Line

    [CAT#: S01YF-1123-KX149]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1028 Magic™ Human ALK2(ACVR1) in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    ACVR1
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    C2C12; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Ocular Research
    Related Diseases
    Fibrodysplasia Ossificans Progressiva and Epicanthus. Among its related pathways are ALK1 signaling events and Akt Signaling
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The activin receptor type-1 (ACVR1) protein, a member of the BMP type I receptor protein family, is made using instructions provided by the ACVR1 gene. BMP receptors cross the cell membrane, allowing the protein to protrude from the outside of the cell on one end while staying inside the cell on the other. Because of this configuration, receptors are able to absorb signals from the external environment and transfer them within the cell to influence its growth and operation. Numerous bodily tissues, including cartilage and skeletal muscle, contain the ACVR1 protein. It aids in the regulation of muscle and bone growth and development, including the progressive replacement of cartilage by bone. From infancy to early adulthood, this procedure is part of the natural skeletal maturation process. The customized ACVR1 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Lena

    The ACVR1 cell line I purchased was incredibly effective in my research. Sep 15 2022

    chat Verified Customer

    chat Bob

    A very stable ACVR1 cell line, especially as there has not been much variation change during my use. Mar 09 2023

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Acvr1G328V Hyperactivates BMP Signaling and Stimulates Glial Cell Proliferation

    Adenoviruses expressing GFP (Ad-GFP) or GFP plus Cre (Ad-GFP-Cre) were used to transduce cells. Ad-GFP-Cre induced recombination of the conditional allele and phosphorylated SMAD1, the canonical BMP signaling effector, in Acvr1floxG328V/+ cells, but not SMAD2.

    Ref: Fortin, Jerome, et al. "Mutant ACVR1 arrests glial cell differentiation to drive tumorigenesis in pediatric gliomas." Cancer Cell 37.3 (2020): 308-323.

    Pubmed: 32142668

    DOI: 10.1016/j.ccell.2020.02.002

    Research Highlights

    These findings gave rise to a potential new therapeutic approach for FOP and reveal a novel mechanism of extraskeletal bone production in the disease.
    Hino, Kyosuke, et al. "Neofunction of ACVR1 in fibrodysplasia ossificans progressiva." Proceedings of the National Academy of Sciences 112.50 (2015): 15438-15443.
    Pubmed: 26621707   DOI: 10.1073/pnas.1510540112

    These findings reveal a new characteristic of FOP-mutant ACVR1 and suggest that anti-ACVR1 antibodies are not a suitable treatment option for FOP.
    Aykul, Senem, et al. "Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1." The Journal of Clinical Investigation 132.12 (2022).
    Pubmed: 35511419   DOI: 10.1172/JCI153792

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare